licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2012.12.20; Accepted: 2013.04.15; Published: 2013.07.10 Novel biomarkers are required to improve prognostic predictions obtained with lung cancer staging systems. This study of 62 surgically-treated Non-Small Cell Lung Cancer (NSCLC) patients had two objectives: i) to compare the predictive value of T-stage classifications between the 6th and 7th editions of the Tumor, Node, and Metastasis staging system (TNM); and ii) to examine the association of Pkp1 and/or Krt15 gene expression with survival and outcomes. Multivariate and Kaplan-Meier survival analyses were performed, examin...
The 1997 International staging system (ISS) classification separated stage III non-small cell lung c...
Lung cancer is the most common cause of cancer mortality worldwide, and non-small cell lung cancer (...
Background/Aim. Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and a ...
Journal Article; Research Support, Non-U.S. Gov't;Novel biomarkers are required to improve prognosti...
NSCLC (non-small cell lung cancer) comprises about 80% of all lung cancer cases worldwide. Surgery i...
BACKGROUND: Current staging methods are inadequate for predicting the outcome of treatment of non-sm...
Abstract Background The current TNM staging system is far from perfect in predicting the survival of...
BACKGROUND: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, generating an eno...
There remains a critical need for improved staging of non-small-cell lung cancer, as recurrence and ...
Non-small cell lung cancer (NSCLC) constitutes a clinically, histologically, and genetically heterog...
Purpose: The National Lung Cancer Screening Trial has confirmed that lung cancer mortality can be re...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
The 1997 International staging system (ISS) classification separated stage III non-small cell lung c...
Lung cancer is the most common cause of cancer mortality worldwide, and non-small cell lung cancer (...
Background/Aim. Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and a ...
Journal Article; Research Support, Non-U.S. Gov't;Novel biomarkers are required to improve prognosti...
NSCLC (non-small cell lung cancer) comprises about 80% of all lung cancer cases worldwide. Surgery i...
BACKGROUND: Current staging methods are inadequate for predicting the outcome of treatment of non-sm...
Abstract Background The current TNM staging system is far from perfect in predicting the survival of...
BACKGROUND: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological cla...
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, generating an eno...
There remains a critical need for improved staging of non-small-cell lung cancer, as recurrence and ...
Non-small cell lung cancer (NSCLC) constitutes a clinically, histologically, and genetically heterog...
Purpose: The National Lung Cancer Screening Trial has confirmed that lung cancer mortality can be re...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
The 1997 International staging system (ISS) classification separated stage III non-small cell lung c...
Lung cancer is the most common cause of cancer mortality worldwide, and non-small cell lung cancer (...
Background/Aim. Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and a ...